Xencor, Inc Litigation Settlement, Amount (Deprecated 2017-01-31)
Xencor, Inc (XNCR) had Litigation Settlement, Amount (Deprecated 2017-01-31) of -$2.38 million as of 2016-09-27, per its 10-Q filed 2017-11-08.
Discontinued › Notes › Commitment and Contingencies
us-gaap:LitigationSettlementAmount · last filed 2017-11-08
| Period end | Litigation Settlement, Amount (Deprecated 2017-01-31) | Litigation Settlement, Amount (Deprecated 2017-01-31) as first filed | Litigation Settlement, Amount (Deprecated 2017-01-31) 12 month | Litigation Settlement, Amount (Deprecated 2017-01-31) 12 month as first filed |
|---|---|---|---|---|
| 2016-09-27 | -$2.38M 10-Q · filed 2017-11-08 | $2.38M 10-Q · filed 2016-11-02 | ||
| 2015-12-31 | -$950.00K 10-Q · filed 2017-11-08 | $950.00K 10-Q · filed 2016-05-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |